GGrantIndex
← Leaderboards

Taosheng Chen

St. Jude Children'S Research Hospital

$8,225,244
Attributed
$9,447,823
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY201025
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,447,823 · 5

By mechanism

R01$3,898,876 · 3
R35$3,705,098 · 1
U54$1,843,849 · 1

Top collaborators

Most similar at St. Jude Children'S Research Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsTreatment EfficacyEnzymesIn VivoPreventXenobioticsRegulationPregnane X ReceptorGenetic TranscriptionCellsMalignant NeoplasmsAffectDrug ResistanceConstitutive Androstane ReceptorStructureBiological AvailabilityReceptorTreatment FailureIn VitroResponsePathway InteractionsDrug ToxicityDiabetes MellitusProtein Protein Interaction

Grant awards (26)

Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition$448,750
R35 · FY2025 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition$448,750
R35 · FY2024 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition$448,750
R35 · FY2023 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition$380,216
R35 · FY2022 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition$448,750
R35 · FY2021 · GM · contact PI
Development of small molecules to target KDM4B$410,606
R01 · FY2021 · CA
Development of small molecules to target KDM4B$410,606
R01 · FY2020 · CA
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$300,124
R35 · FY2020 · GM · contact PI
Project 4$25,642
U54 · FY2020 · CA · contact PI
Project 4$22,804
U54 · FY2020 · CA · contact PI
Project 4$1,795,403
U54 · FY2019 · CA · contact PI
Development of small molecules to target KDM4B$398,287
R01 · FY2019 · CA
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$343,922
R35 · FY2019 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$119,154
R35 · FY2019 · GM · contact PI
Development of small molecules to target KDM4B$410,606
R01 · FY2018 · CA
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$405,239
R35 · FY2018 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$300,124
R35 · FY2017 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$61,317
R35 · FY2017 · GM · contact PI
Regulation of drug disposition by a novel microRNA-mediated pathway$332,500
R01 · FY2016 · GM · contact PI
Regulation of xenobiotic receptors PXR and CAR: implications in drug disposition$2
R35 · FY2016 · GM · contact PI
Regulation of drug disposition by a novel microRNA-mediated pathway$332,500
R01 · FY2015 · GM · contact PI
Regulation of drug disposition by a novel microRNA-mediated pathway$332,500
R01 · FY2014 · GM · contact PI
Regulation of PXR by cell cycle and phosphorylation$304,444
R01 · FY2013 · GM · contact PI
Regulation of PXR by cell cycle and phosphorylation$315,530
R01 · FY2012 · GM · contact PI
Regulation of PXR by cell cycle and phosphorylation$323,697
R01 · FY2011 · GM · contact PI
Regulation of PXR by cell cycle and phosphorylation$327,600
R01 · FY2010 · GM · contact PI